tiprankstipranks
Trending News
More News >
ME Therapeutics Holdings, Inc. (TSE:METX)
:METX
Canadian Market

ME Therapeutics Holdings, Inc. (METX) Income Statement

Compare
10 Followers

ME Therapeutics Holdings, Inc. Income Statement

Last quarter (Q4 2024), ME Therapeutics Holdings, Inc.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q4, ME Therapeutics Holdings, Inc.'s net income was $-312.04K. See ME Therapeutics Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Aug 24Aug 23Sep 22
Total Revenue
$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―
Depreciation and Amortization
$ 39.00$ 49.00$ ―
EBITDA
$ -1.29M$ -6.51M$ -57.46K
Operating Income
$ -1.37M$ -6.54M$ -60.28K
Other Income/Expenses
$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―
Net Income
$ -1.29M$ -6.52M$ -57.46K
Per Share Metrics
Basic EPS
$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

ME Therapeutics Holdings, Inc. Earnings and Revenue History